Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Motexafin Gadolinium with Zevalin in Relapsed/Refractory NHL
NCT00089284Phase 2Terminated
- Sponsor
- Northwestern University
- Start
- Oct 2003
- Primary completion
- Jan 2007
- Modality
- Orthosteric Ligands, Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of motexafin gadolinium in non-Hodgkin lymphoma (NHL), sponsored by Northwestern University. Started Oct 2003; status: terminated.
02
Drugs
motexafin gadolinium
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00089284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089284.